Skip to main content
. 2018 Jul 18;49(5):828–842. doi: 10.1017/S0033291718001484

Table 5.

Mean costs (£) and outcome per participant over the 30-months follow-up period (CC1)*

Intervention arm (I) (N = 507) Control arm (C) (N = 500) Unadjusted mean difference (I-C) Adjusted mean difference (I-C)*
Mean (s.e.) Mean (s.e.) Estimate 95% CI p value
Costs (£)
Baseline 119.82 (15.20) 115.99 (10.87) 3.83 −11.67 −49.90 to 26.55 0.55
Intervention 11.52 (0.00) 0.00 (0.00) 11.52 . . .
Hospital 373.49 (0.70) 354.59 (36.80) 18.90 21.60 −70.13 to 113.33 0.64
Community 60.24 (0.70) 74.91 (8.26) −14.67 −12.42 −24.12 to 9.28 0.26
Medication 2.93 (0.70) 19.08 (7.06) −16.16 −9.11 −25.93 to 7.71 0.29
Accommodation 0.00 (0.00) 49.36 (27.66) −49.63 −49.70 −127.21 to 27.80 0.21
Productivity loss 76.60 (57.18) 27.67 (40.58) 48.93 −70.41 −42.51 to 183.33 0.22
Total 524.16 (90.60) 528.14 (64.31) −3.98 30.24 −140.98 to 201.47 0.73
Outcome
SDQ total difficulties 5.17 (5.49) 5.39 (6.05) −0.22 −0.54 −1.68 to 0.61 0.36

*CC1 – partially adjusted complete case analysis (primary analysis).